Pharmacologic considerations for antiviral drug development.

about

Polyanions--a lost chance in the fight against HIV and other virus diseases?

P2860

Q34009817-CD19ACB2-21A7-4CC0-ABFA-3A11C0D9CD91

P2860

Pharmacologic considerations for antiviral drug development.

Item

http://www.wikidata.org/entity/Q41172065

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Pharmacologic considerations for antiviral drug development.

@en

type

Item

label

Pharmacologic considerations for antiviral drug development.

@en

prefLabel

Pharmacologic considerations for antiviral drug development.

@en

P1476

Pharmacologic considerations for antiviral drug development.

@en

P2093

C V Fletcher

http://www.w3.org/2001/XMLSchema#string

P2860

Resolution of racemic carbovir and selective inhibition of human immunodeficiency virus by the (-) enantiomer

Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection.

Effect of acyclovir on the proliferation of human fibroblasts and peripheral blood mononuclear cells.

Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure.

Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells.

Foscarnet for suppression of human immunodeficiency virus replication.

Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteers

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

Continuous infusion of high-dose acyclovir for serious herpesvirus infections.

Effect of acyclovir and interferon on human hematopoietic progenitor cells.

P304

972-977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/106002809603000912

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1996-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8876859

http://www.w3.org/2001/XMLSchema#string

Pharmacologic considerations for antiviral drug development.

about

P2860

P2860

Pharmacologic considerations for antiviral drug development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698